Haematopoietic growth factor clinical trials

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

This study is for people with early-stage Hodgkin Lymphoma. It compares two chemotherapy treatments, ABVD and A2VD, to see which works best. Treatment is adjusted based on scans, and patients are followed for at least 5 years.